ACE2 and COVID-19: In the light of this evidence, and considering the critical role of ACE2-SARS-CoV-2 interplay in COVID-19, we thought that Gitelman and Bartter patients, with their increased ACE2 level, could be a good model to investigate susceptibility to developing COVID-19 infection.